Alteration of splicing signals in a genomic/cDNA hybrid VEGF gene to modify the ratio of expressed VEGF isoforms enhances safety of angiogenic gene therapy-Reference-Cited by-同舟云学术

Alteration of splicing signals in a genomic/cDNA hybrid VEGF gene to modify the ratio of expressed VEGF isoforms enhances safety of angiogenic gene therapy

Published:2005-10 Issue:4 Volume:12 Page:716-724
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Amano Hideki,Hackett Neil R.,Kaner Robert J.,Whitlock Paul,Rosengart Todd K.,Crystal Ronald G.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference44 articles.

1. Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model;Takeshita;J. Clin. Invest.,1994

2. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia;Takeshita;Biochem. Biophys. Res. Commun.,1996

3. Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor;Magovern;Hum. Gene Ther.,1997

4. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion;Mack;J. Vasc. Surg.,1998

5. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia;Baumgartner;Circulation,1998

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial;Circulation: Cardiovascular Interventions;2024-05

2. Safety and biodistribution of XC001 (encoberminogene rezmadenovec) gene therapy in rats: a potential therapy for cardiovascular diseases;Gene Therapy;2023-08-18

3. EXACT Trial: Results of the Phase 1 Dose-Escalation Study;Circulation: Cardiovascular Interventions;2023-08

4. Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective;Journal of Molecular Medicine;2022-05-24

5. Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations;American Heart Journal;2021-11